688331.SH
荣昌生物
SSE · Healthcare · Biotechnology · CN
CNY 116.42
−7.24%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 16.95x
- P/E 2027E
- 81.10x
- P/E 2028E
- 47.11x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 92.60x
- PEG TTM
- —
- Price / book
- 16.73x
- Price / sales
- 20.74x
- Price / cash flow
- 277.65x
Enterprise value
- Enterprise value
- CNY 70.8B
- EV / sales
- 20.95x
- EV / EBITDA
- 71.88x
- EV / EBIT
- 54.38x
- Market cap
- CNY 65.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026